Attached files

file filename
10-Q - QUARTERLY REPORT - BLONDER TONGUE LABORATORIES INCf10q0920_blondertongue.htm
EX-31.2 - CERTIFICATION - BLONDER TONGUE LABORATORIES INCf10q0920ex31-2_blonder.htm
EX-31.1 - CERTIFICATION - BLONDER TONGUE LABORATORIES INCf10q0920ex31-1_blonder.htm
EX-10.7 - AMENDMENT NO. 3 TO 2016 EMPLOYEE EQUITY INCENTIVE PLAN - BLONDER TONGUE LABORATORIES INCf10q0920ex10-7_blonder.htm
EX-10.6 - AMENDMENT NO. 2 TO 2016 DIRECTOR EQUITY INCENTIVE PLAN - BLONDER TONGUE LABORATORIES INCf10q0920ex10-6_blonder.htm
EX-10.5 - AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED DIRECTOR STOCK PURCHASE PLAN - BLONDER TONGUE LABORATORIES INCf10q0920ex10-5_blonder.htm
EX-10.4 - THIRD AMENDED AND RESTATED DIRECTOR STOCK PURCHASE PLAN - BLONDER TONGUE LABORATORIES INCf10q0920ex10-4_blonder.htm

Exhibit 32.1

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

To the knowledge of each of the undersigned, this Report on Form 10-Q for the quarter ended September 30, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Blonder Tongue Laboratories, Inc. for the applicable reporting period.

 

Date: November 12, 2020By: /s/ Edward R. Grauch
  Edward R. Grauch,
Chief Executive Officer

 

 

 By:/s/ Eric Skolnik
  Eric Skolnik,
Chief Financial Officer